1001 related articles for article (PubMed ID: 32987097)
1. Survey of antibiotic and antifungal prescribing in patients with suspected and confirmed COVID-19 in Scottish hospitals.
Seaton RA; Gibbons CL; Cooper L; Malcolm W; McKinney R; Dundas S; Griffith D; Jeffreys D; Hamilton K; Choo-Kang B; Brittain S; Guthrie D; Sneddon J
J Infect; 2020 Dec; 81(6):952-960. PubMed ID: 32987097
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic prescribing for respiratory tract infection in patients with suspected and proven COVID-19: results from an antibiotic point prevalence survey in Scottish hospitals.
Seaton RA; Cooper L; Gibbons CL; Malcolm W; Choo-Kang B; Griffith D; Dundas S; Brittain S; Hamilton K; Jeffreys D; McKinney R; Guthrie D; Sneddon J
JAC Antimicrob Resist; 2021 Jun; 3(2):dlab078. PubMed ID: 34223137
[TBL] [Abstract][Full Text] [Related]
3. A point prevalence survey to assess antibiotic prescribing in patients hospitalized with confirmed and suspected coronavirus disease 2019 (COVID-19).
Tan SH; Ng TM; Tay HL; Yap MY; Heng ST; Loo AYX; Teng CB; Lee TH
J Glob Antimicrob Resist; 2021 Mar; 24():45-47. PubMed ID: 33307276
[TBL] [Abstract][Full Text] [Related]
4. Establishing a baseline for a national paediatric antimicrobial stewardship programme.
Gibbons CL; Malcolm W; Sneddon J; Doherty C; Cairns S; Milne A; Llano M; Reilly JS
J Antimicrob Chemother; 2019 Oct; 74(10):3104-3110. PubMed ID: 31299069
[TBL] [Abstract][Full Text] [Related]
5. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship.
Rothe K; Feihl S; Schneider J; Wallnöfer F; Wurst M; Lukas M; Treiber M; Lahmer T; Heim M; Dommasch M; Waschulzik B; Zink A; Querbach C; Busch DH; Schmid RM; Schneider G; Spinner CD
Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):859-869. PubMed ID: 33140176
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial stewardship in the UK during the COVID-19 pandemic: a population-based cohort study and interrupted time-series analysis.
Rezel-Potts E; L'Esperance V; Gulliford MC
Br J Gen Pract; 2021 May; 71(706):e331-e338. PubMed ID: 33690150
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.
Langford BJ; So M; Raybardhan S; Leung V; Soucy JR; Westwood D; Daneman N; MacFadden DR
Clin Microbiol Infect; 2021 Apr; 27(4):520-531. PubMed ID: 33418017
[TBL] [Abstract][Full Text] [Related]
8. Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.
Rawson TM; Moore LSP; Zhu N; Ranganathan N; Skolimowska K; Gilchrist M; Satta G; Cooke G; Holmes A
Clin Infect Dis; 2020 Dec; 71(9):2459-2468. PubMed ID: 32358954
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial stewardship in the ICU in COVID-19 times: the known unknowns.
Schouten J; De Waele J; Lanckohr C; Koulenti D; Haddad N; Rizk N; Sjövall F; Kanj SS;
Int J Antimicrob Agents; 2021 Oct; 58(4):106409. PubMed ID: 34339777
[TBL] [Abstract][Full Text] [Related]
10. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK.
Gharbi M; Doerholt K; Vergnano S; Bielicki JA; Paulus S; Menson E; Riordan A; Lyall H; Patel SV; Bernatoniene J; Versporten A; Heginbothom M; Goossens H; Sharland M;
BMJ Open; 2016 Nov; 6(11):e012675. PubMed ID: 27810974
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey.
Abubakar U
BMC Infect Dis; 2020 Jan; 20(1):86. PubMed ID: 32000722
[TBL] [Abstract][Full Text] [Related]
12. The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals.
Frenette C; Sperlea D; German GJ; Afra K; Boswell J; Chang S; Goossens H; Grant J; Lefebvre MA; McGeer A; Mertz D; Science M; Versporten A; Thirion DJG
Antimicrob Resist Infect Control; 2020 Jul; 9(1):104. PubMed ID: 32653046
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial.
Chen JZ; Hoang HL; Yaskina M; Kabbani D; Doucette KE; Smith SW; Lau C; Stewart J; Remtulla S; Zurek K; Schultz M; Koriyama-McKenzie H; Cervera C
Lancet Infect Dis; 2023 Jun; 23(6):673-682. PubMed ID: 36716763
[TBL] [Abstract][Full Text] [Related]
14. Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey.
Mustafa ZU; Saleem MS; Ikram MN; Salman M; Butt SA; Khan S; Godman B; Seaton RA
Pathog Glob Health; 2022 Oct; 116(7):421-427. PubMed ID: 34783630
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial use in acute care hospitals: national point prevalence survey on healthcare-associated infections and antimicrobial use, Switzerland, 2017.
Zingg W; Metsini A; Gardiol C; Balmelli C; Behnke M; Troillet N; Widmer A; Pittet D;
Euro Surveill; 2019 Aug; 24(33):. PubMed ID: 31431211
[TBL] [Abstract][Full Text] [Related]
16. Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial.
Boere TM; van Buul LW; Hopstaken RM; van Tulder MW; Twisk JWMR; Verheij TJM; Hertogh CMPM
BMJ; 2021 Sep; 374():n2198. PubMed ID: 34548288
[TBL] [Abstract][Full Text] [Related]
17. Linezolid use in German acute care hospitals: results from two consecutive national point prevalence surveys.
Kramer TS; Schwab F; Behnke M; Hansen S; Gastmeier P; Aghdassi SJS
Antimicrob Resist Infect Control; 2019; 8():159. PubMed ID: 31649816
[TBL] [Abstract][Full Text] [Related]
18. Coinfections with Other Respiratory Pathogens among Patients with COVID-19.
Sreenath K; Batra P; Vinayaraj EV; Bhatia R; SaiKiran K; Singh V; Singh S; Verma N; Singh UB; Mohan A; Bhatnagar S; Trikha A; Guleria R; Chaudhry R
Microbiol Spectr; 2021 Sep; 9(1):e0016321. PubMed ID: 34287033
[TBL] [Abstract][Full Text] [Related]
19. Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study.
Russell CD; Fairfield CJ; Drake TM; Turtle L; Seaton RA; Wootton DG; Sigfrid L; Harrison EM; Docherty AB; de Silva TI; Egan C; Pius R; Hardwick HE; Merson L; Girvan M; Dunning J; Nguyen-Van-Tam JS; Openshaw PJM; Baillie JK; Semple MG; Ho A;
Lancet Microbe; 2021 Aug; 2(8):e354-e365. PubMed ID: 34100002
[TBL] [Abstract][Full Text] [Related]
20. Electronically delivered interventions to reduce antibiotic prescribing for respiratory infections in primary care: cluster RCT using electronic health records and cohort study.
Gulliford MC; Juszczyk D; Prevost AT; Soames J; McDermott L; Sultana K; Wright M; Fox R; Hay AD; Little P; Moore M; Yardley L; Ashworth M; Charlton J
Health Technol Assess; 2019 Mar; 23(11):1-70. PubMed ID: 30900550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
